Epidemiology of SARS-CoV-2 Infection in Ethiopia: A Systematic Review and Meta-Analysis

被引:1
|
作者
Gedefie, Alemu [1 ]
Tilahun, Mihret [1 ]
Fiseha, Mesfin [1 ]
Alemayehu, Ermiyas [1 ]
Shibabaw, Agumas [1 ]
Bisetegn, Habtye [1 ]
Debash, Habtu [1 ]
Kassa, Yeshimebet [1 ]
Ali, Abdurrahman [1 ]
Seid, Abdurahaman [1 ]
Tesfaye, Melkam [1 ]
Mohammed, Ousman [1 ]
Kebede, Berhanu [2 ]
机构
[1] Wollo Univ, Coll Med & Hlth Sci, Dept Med Lab Sci, Dessie 1145, Ethiopia
[2] Samara Univ, Coll Med & Hlth Sci, Dept Biomed Sci, Samara 132, Ethiopia
来源
COVID | 2023年 / 3卷 / 05期
关键词
COVID-19; SARS-CoV-2; Ethiopia; prevalence; epidemiology; coronavirus disease 2019; severe acute respiratory syndrome coronavirus 2;
D O I
10.3390/covid3050052
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Introduction: The Coronavirus disease of 2019 (COVID-19) is a catastrophic emerging global health threat caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). COVID-19 has a wide range of complications and sequelae. It is devastating in developing countries, causing serious health and socioeconomic crises as a result of the increasingly overburdened healthcare system. This study was conducted to determine the prevalence of SARS-CoV-2 infection in Ethiopia. Methods: Electronic databases, such as PubMed, Google Scholar, Web of Science, Research Gate, Embase, and Scopus were thoroughly searched from March to April 2022 to identify relevant studies. The quality of the included studies was evaluated using the Newcastle-Ottawa Quality scale for cross-sectional studies. STATA-12 was used for analysis. A random-effects model was used to compute the pooled prevalence of SARS-CoV-2 infection. The heterogeneity was quantified by using the I2 value. Subgroup analysis was done for sex, age of study subjects, population type, diagnostic methods, and publication year. Publication bias was assessed using a funnel plot and Egger's test. A sensitivity analysis was also done. Result: 11 studies consisting of 35,376 study participants (15,759 male and 19,838 female) were included in this systematic review and meta-analysis. The pooled prevalence of SARS-CoV-2 was 8.83%. There was substantial heterogeneity, with an I2 value of 99.3%. The pooled prevalence of SARS-CoV-2 was higher in males (9.27%) than in females (8.8%). According to the publication year, a higher prevalence was obtained in 2021 (12.69%). Similarly, it was higher in the population of specific groups (16.65%) than in the general population (5.75%). Conclusion: the national pooled prevalence of SARS-CoV-2 infection in the Ethiopian population was 8.83%. This indicates that the burden of COVID-19 is still high, which urges routine screening and appropriate treatment.
引用
收藏
页码:703 / 714
页数:12
相关论文
共 50 条
  • [41] Postvaccination SARS-CoV-2 infection among healthcare workers: A systematic review and meta-analysis
    Chandan, Saurabh
    Khan, Shahab R.
    Deliwala, Smit
    Mohan, Babu P.
    Ramai, Daryl
    Chandan, Ojasvini C.
    Facciorusso, Antonio
    JOURNAL OF MEDICAL VIROLOGY, 2022, 94 (04) : 1428 - 1441
  • [42] Co-infection of SARS-CoV-2 and influenza viruses: A systematic review and meta-analysis
    Thi Loi Dao
    Van Thuan Hoang
    Colson, Philippe
    Million, Matthieu
    Gautret, Philippe
    JOURNAL OF CLINICAL VIROLOGY PLUS, 2021, 1 (03):
  • [43] Severe Outcomes Associated With SARS-CoV-2 Infection in Children: A Systematic Review and Meta-Analysis
    Sumner, Madeleine W.
    Kanngiesser, Alicia
    Lotfali-Khani, Kosar
    Lodha, Nidhi
    Lorenzetti, Diane
    Funk, Anna L.
    Freedman, Stephen B.
    FRONTIERS IN PEDIATRICS, 2022, 10
  • [44] Pulmonary function in children post -SARS-CoV-2 infection: a systematic review and meta-analysis
    Elham Bakhtiari
    Nasrin Moazzen
    BMC Pediatrics, 24
  • [45] Association of SARS-CoV-2 Vaccination or Infection With Bell Palsy A Systematic Review and Meta-analysis
    Rafati, Ali
    Pasebani, Yeganeh
    Jameie, Melika
    Yang, Yuchen
    Jameie, Mana
    Ilkhani, Saba
    Amanollahi, Mobina
    Sakhaei, Delaram
    Rahimlou, Mehran
    Kheradmand, Amir
    JAMA OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2023, 149 (06) : 493 - 504
  • [46] The clinical characteristics of pediatric inpatients with SARS-CoV-2 infection: A meta-analysis and systematic review
    Ma, Xuefeng
    Liu, Shousheng
    Chen, Lizhen
    Zhuang, Likun
    Zhang, Jie
    Xin, Yongning
    JOURNAL OF MEDICAL VIROLOGY, 2021, 93 (01) : 234 - 240
  • [47] PSYCHIATRIC SEQUELAE OF THE SARS-COV-2 INFECTION IN CHILDREN AND ADOLESCENTS: A SYSTEMATIC REVIEW AND META-ANALYSIS
    Japi, Abha R.
    Aber, Rachel B.
    Clay, John
    Biazon, Therese
    Vazquez, Nicholas
    Khan, Humza
    Saad, George
    Dergham, Reem
    LaFever, Steven T.
    Zhao, Jonny
    Smith, Abigail
    Faraone, Stephen V.
    Zhang-James, Yanli
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2024, 63 (10): : S289 - S290
  • [48] Clinical Features and Outcome of SARS-CoV-2 Infection in Children: A Systematic Review and Meta-analysis
    Jitendra Meena
    Jaivinder Yadav
    Lokesh Saini
    Arushi Yadav
    Jogender Kumar
    Indian Pediatrics, 2020, 57 : 820 - 826
  • [49] Past SARS-CoV-2 infection protection against re-infection: a systematic review and meta-analysis
    Stein, Caroline
    Nassereldine, Hasan
    Sorensen, Reed J. D.
    Amlag, Joanne
    Bisignano, Catherine
    Byrne, Sam
    Castro, Emma
    Coberly, Kaleb
    Collins, James K.
    Dalos, Jeremy
    Daoud, Farah
    Deen, Amanda
    Gakidou, Emmanuela
    Giles, John R.
    Hulland, Erin N.
    Huntley, Bethany M.
    Kinzel, Kasey E.
    Lozano, Rafael
    Mokdad, Ali H.
    Pham, Tom
    Pigott, David M.
    Reiner Jr, Robert C.
    Vos, Theo
    Hay, Simon, I
    Murray, Christopher J. L.
    Lim, Stephen S.
    LANCET, 2023, 401 (10379): : 833 - 842
  • [50] Protective effectiveness of previous infection against subsequent SARS-Cov-2 infection: systematic review and meta-analysis
    Hu, Wei-Hua
    Cai, Huan-Le
    Yan, Huan-Chang
    Wang, Han
    Sun, Hui-Min
    Wei, Yong-Yue
    Hao, Yuan-Tao
    FRONTIERS IN PUBLIC HEALTH, 2024, 12